An article published in Life Science Compliance Update and Policy and Medicine shines a spotlight on drug pricing today, and how it could evolve.
The authors of the article, titled “The Day After Tomorrow – The Drug Pricing Transparency Chorus Grows Louder,” say this year will “continue to be a time of high uncertainty and an ever-increasing workload” for pharmaceutical compliance professionals.
To download the full article from CBI’s website, click here.
